Cargando…

Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions

Current recommendations for the use of intravenous iron therapy in the management of anaemia in patients with chronic kidney disease (CKD) are based on limited clinical evidence. Since the publication of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Anaemia in...

Descripción completa

Detalles Bibliográficos
Autor principal:	Macdougall, Iain C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716151/ https://www.ncbi.nlm.nih.gov/pubmed/29225819 http://dx.doi.org/10.1093/ckj/sfx043

Ejemplares similares

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Special issue: iron therapy in patients with chronic kidney disease
por: Macdougall, Iain C
Publicado: (2017)

Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial
por: Kassianides, Xenophon, et al.
Publicado: (2022)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
por: Macdougall, Iain C., et al.
Publicado: (2014)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2014)

New options for the anemia of chronic kidney disease
por: Coyne, Daniel W., et al.
Publicado: (2017)

Safety of intravenous iron use in chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2016)

Safety concerns about intravenous iron therapy in patients with chronic kidney disease
por: Del Vecchio, Lucia, et al.
Publicado: (2016)

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
por: Bhandari, S., et al.
Publicado: (2021)

A randomized trial of intravenous and oral iron in chronic kidney disease
por: Agarwal, Rajiv, et al.
Publicado: (2015)

The future of intravenous iron in nephrology
por: Coyne, Daniel W.
Publicado: (2011)

Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies
por: Franca Gois, Pedro Henrique, et al.
Publicado: (2018)

Iron and Heart Failure: Diagnosis, Therapies, and Future Directions
por: Ghafourian, Kambiz, et al.
Publicado: (2020)

Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
por: Macdougall, Iain C., et al.
Publicado: (2017)

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice
por: Richards, Toby, et al.
Publicado: (2021)

Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease
por: Nuhu, Faisal, et al.
Publicado: (2019)

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
por: Macdougall, Iain C., et al.
Publicado: (2020)

Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
por: Macdougall, Iain C., et al.
Publicado: (2017)

The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial
por: Greenwood, Sharlene A., et al.
Publicado: (2022)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
por: Canonico, Mario Enrico, et al.
Publicado: (2023)

Intravenous iron and erythropoiesis‐stimulating agents in haemodialysis: A systematic review and meta‐analysis
por: Roger, Simon D, et al.
Publicado: (2017)

Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease
por: Roger, Simon D
Publicado: (2017)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2023)

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
por: Yu, Ji Hee, et al.
Publicado: (2022)

Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
por: Akter, Shamima, et al.
Publicado: (2023)

Iron metabolism: current facts and future directions
por: Tandara, Leida, et al.
Publicado: (2012)

Intravenous Iron Therapy with Saccharated Iron Oxide
por: Deshmukh, P. L.
Publicado: (1952)

Childbirth Pain, Labor Epidural Analgesia, and Postpartum Depression: Recent Evidence and Future Directions
por: Du, Weijia, et al.
Publicado: (2022)

The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
por: Tirandi, Amedeo, et al.
Publicado: (2021)

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions
por: Perone, Francesco, et al.
Publicado: (2023)

Measurement of iron status in chronic kidney disease
por: Hayes, Wesley
Publicado: (2018)

Biomarkers of iron metabolism in chronic kidney disease
por: Tomasz, Glogowski, et al.
Publicado: (2020)

Intravenous iron therapy for patients with heart failure: expanding body of evidence
por: Adlbrecht, Christopher
Publicado: (2019)

Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions
por: Kreidieh, Malek, et al.
Publicado: (2022)

Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence
por: Berns, Jeffrey S
Publicado: (2017)

Recent advances in understanding of chronic kidney disease
por: Yamaguchi, Junna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1fm9u8l6bqjpvq9q4mri19ljcn